Literature DB >> 2953289

Aortic root dilatation as a cause of isolated, severe aortic regurgitation. Prevalence, clinical and echocardiographic patterns, and relation to left ventricular hypertrophy and function.

M J Roman, R B Devereux, N W Niles, C Hochreiter, P Kligfield, N Sato, M C Spitzer, J S Borer.   

Abstract

To evaluate the relation of aortic root dilatation to aortic regurgitation, we examined clinical, echocardiographic, and radionuclide cineangiographic findings in 102 patients with severe aortic regurgitation. Aortic root dilatation was the only apparent cause in 31 patients (30%), exceeding in prevalence any valvular cause, and was independently associated only with older age (p less than 0.001). Echocardiography showed dilatation to be either localized to the sinuses of Valsalva or to be generalized. At initial evaluation, patients with generalized dilatation had severer abnormalities of left ventricular size and function than those with localized or no dilatation. Aortic valves were subsequently replaced in more patients with generalized than localized dilatation during 28 +/- 17 month follow-up (9 of 15 patients compared with 2 of 15, p less than 0.03). Thus, idiopathic aortic root dilatation is the commonest definable cause of severe aortic regurgitation; aortic root dilatation is associated independently with age but not blood pressure; and generalized aortic root dilatation is associated with marked ventricular dilatation, hypertrophy, and dysfunction.

Entities:  

Mesh:

Year:  1987        PMID: 2953289     DOI: 10.7326/0003-4819-106-6-800

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


  28 in total

Review 1.  Clinical significance of the bicuspid aortic valve.

Authors:  C Ward
Journal:  Heart       Date:  2000-01       Impact factor: 5.994

2.  [Surgical treatment of cardiovascular manifestations of Marfan's syndrome].

Authors:  R Lange; E Ebert
Journal:  Herz       Date:  1999-12       Impact factor: 1.443

3.  Normal limits in relation to age, body size and gender of two-dimensional echocardiographic aortic root dimensions in persons ≥15 years of age.

Authors:  Richard B Devereux; Giovanni de Simone; Donna K Arnett; Lyle G Best; Eric Boerwinkle; Barbara V Howard; Dalane Kitzman; Elisa T Lee; Thomas H Mosley; Alan Weder; Mary J Roman
Journal:  Am J Cardiol       Date:  2012-07-06       Impact factor: 2.778

Review 4.  Dilation of the thoracic aorta: medical and surgical management.

Authors:  P Nataf; E Lansac
Journal:  Heart       Date:  2006-09       Impact factor: 5.994

5.  Root remodeling for aortic root dilatation.

Authors:  Hans-Joachim Schäfers; Diana Aicher
Journal:  Ann Cardiothorac Surg       Date:  2013-01

Review 6.  Management decisions in valvular heart disease: the role of radionuclide-based assessment of ventricular function and performance.

Authors:  J S Borer; D Wencker; C Hochreiter
Journal:  J Nucl Cardiol       Date:  1996 Jan-Feb       Impact factor: 5.952

7.  A comparative analysis of ECG-gated steady state free precession magnetic resonance imaging versus transthoracic echocardiography for evaluation of aortic root dimensions.

Authors:  Edward T D Hoey; Vijaya Pakala; Rahil H Kassamali; Arul Ganeshan
Journal:  Quant Imaging Med Surg       Date:  2014-10

8.  Aortic annulus and the importance of annuloplasty.

Authors:  Pouya Youssefi; Emmanuel Lansac
Journal:  Indian J Thorac Cardiovasc Surg       Date:  2019-10-07

9.  Survival after Aortic Valve Replacement for Aortic Regurgitation: Prediction from Preoperative Contractility Measurement.

Authors:  Jeffrey S Borer; Phyllis G Supino; Edmund McM Herrold; Antony Innasimuthu; Clare Hochreiter; Karl Krieger; Leonard N Girardi; O Wayne Isom
Journal:  Cardiology       Date:  2018-08-23       Impact factor: 1.869

10.  Rationale and design of the National Registry of Genetically Triggered Thoracic Aortic Aneurysms and Cardiovascular Conditions (GenTAC).

Authors:  Kim A Eagle
Journal:  Am Heart J       Date:  2008-12-17       Impact factor: 4.749

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.